nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmedetomidine—ADRA1D—Amitriptyline—migraine	0.118	0.172	CbGbCtD
Dexmedetomidine—ADRA1B—Amitriptyline—migraine	0.0855	0.125	CbGbCtD
Dexmedetomidine—SLC6A2—Amitriptyline—migraine	0.0781	0.114	CbGbCtD
Dexmedetomidine—CYP1A1—Propranolol—migraine	0.0735	0.108	CbGbCtD
Dexmedetomidine—ADRA2A—Amitriptyline—migraine	0.0704	0.103	CbGbCtD
Dexmedetomidine—CYP2E1—Amitriptyline—migraine	0.0491	0.0719	CbGbCtD
Dexmedetomidine—CYP1A2—Propranolol—migraine	0.0329	0.0481	CbGbCtD
Dexmedetomidine—CYP2D6—Timolol—migraine	0.0304	0.0445	CbGbCtD
Dexmedetomidine—CYP1A2—Amitriptyline—migraine	0.0284	0.0416	CbGbCtD
Dexmedetomidine—CYP2D6—Propranolol—migraine	0.0271	0.0396	CbGbCtD
Dexmedetomidine—CYP1A2—Valproic Acid—migraine	0.0259	0.0379	CbGbCtD
Dexmedetomidine—CYP2D6—Amitriptyline—migraine	0.0234	0.0343	CbGbCtD
Dexmedetomidine—CYP1A2—Verapamil—migraine	0.0225	0.033	CbGbCtD
Dexmedetomidine—CYP2D6—Verapamil—migraine	0.0186	0.0272	CbGbCtD
Dexmedetomidine—SLC6A2—locus ceruleus—migraine	0.00529	0.179	CbGeAlD
Dexmedetomidine—SLC6A2—sympathetic nervous system—migraine	0.00418	0.142	CbGeAlD
Dexmedetomidine—SLC6A2—autonomic nervous system—migraine	0.00281	0.0954	CbGeAlD
Dexmedetomidine—SLC6A2—nerve—migraine	0.00158	0.0536	CbGeAlD
Dexmedetomidine—ADRA2A—peripheral nervous system—migraine	0.00143	0.0486	CbGeAlD
Dexmedetomidine—ADRA2C—trigeminal ganglion—migraine	0.00068	0.0231	CbGeAlD
Dexmedetomidine—SLC6A2—brainstem—migraine	0.000679	0.023	CbGeAlD
Dexmedetomidine—Cardiac disorder—Propranolol—migraine	0.000634	0.00352	CcSEcCtD
Dexmedetomidine—Convulsion—Amitriptyline—migraine	0.000633	0.00351	CcSEcCtD
Dexmedetomidine—Hypertension—Amitriptyline—migraine	0.000631	0.0035	CcSEcCtD
Dexmedetomidine—ADRA1B—head—migraine	0.000621	0.0211	CbGeAlD
Dexmedetomidine—Anxiety—Amitriptyline—migraine	0.00062	0.00344	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Verapamil—migraine	0.000619	0.00343	CcSEcCtD
Dexmedetomidine—Phosphatase alkaline increased—Topiramate—migraine	0.000619	0.00343	CcSEcCtD
Dexmedetomidine—Blood alkaline phosphatase increased—Gabapentin—migraine	0.000614	0.00341	CcSEcCtD
Dexmedetomidine—Hepatic function abnormal—Gabapentin—migraine	0.000611	0.00339	CcSEcCtD
Dexmedetomidine—Dry mouth—Amitriptyline—migraine	0.000608	0.00337	CcSEcCtD
Dexmedetomidine—ADRA1D—head—migraine	0.000607	0.0206	CbGeAlD
Dexmedetomidine—Visual impairment—Verapamil—migraine	0.000606	0.00336	CcSEcCtD
Dexmedetomidine—Confusional state—Amitriptyline—migraine	0.000601	0.00333	CcSEcCtD
Dexmedetomidine—Mental disorder—Propranolol—migraine	0.000599	0.00332	CcSEcCtD
Dexmedetomidine—ADRA1B—nervous system—migraine	0.000589	0.02	CbGeAlD
Dexmedetomidine—Hypoglycaemia—Timolol—migraine	0.000588	0.00326	CcSEcCtD
Dexmedetomidine—Fluid retention—Topiramate—migraine	0.000588	0.00326	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Amitriptyline—migraine	0.000584	0.00324	CcSEcCtD
Dexmedetomidine—Tachycardia—Amitriptyline—migraine	0.000582	0.00323	CcSEcCtD
Dexmedetomidine—Aspartate aminotransferase increased—Valproic Acid—migraine	0.00058	0.00322	CcSEcCtD
Dexmedetomidine—Renal failure acute—Gabapentin—migraine	0.000578	0.00321	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Amitriptyline—migraine	0.000576	0.0032	CcSEcCtD
Dexmedetomidine—ADRA1D—nervous system—migraine	0.000576	0.0195	CbGeAlD
Dexmedetomidine—Alanine aminotransferase increased—Valproic Acid—migraine	0.000568	0.00315	CcSEcCtD
Dexmedetomidine—ADRA1B—central nervous system—migraine	0.000567	0.0192	CbGeAlD
Dexmedetomidine—Atrial fibrillation—Gabapentin—migraine	0.000564	0.00313	CcSEcCtD
Dexmedetomidine—Thirst—Gabapentin—migraine	0.000561	0.00311	CcSEcCtD
Dexmedetomidine—Hypotension—Amitriptyline—migraine	0.000557	0.00309	CcSEcCtD
Dexmedetomidine—ADRA1D—central nervous system—migraine	0.000554	0.0188	CbGeAlD
Dexmedetomidine—Hypoglycaemia—Gabapentin—migraine	0.000547	0.00303	CcSEcCtD
Dexmedetomidine—Agitation—Propranolol—migraine	0.000547	0.00303	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Timolol—migraine	0.000545	0.00302	CcSEcCtD
Dexmedetomidine—ADRA2A—trigeminal ganglion—migraine	0.000542	0.0184	CbGeAlD
Dexmedetomidine—Sweating increased—Valproic Acid—migraine	0.000542	0.00301	CcSEcCtD
Dexmedetomidine—Abnormal vision—Topiramate—migraine	0.00054	0.00299	CcSEcCtD
Dexmedetomidine—Somnolence—Amitriptyline—migraine	0.00053	0.00294	CcSEcCtD
Dexmedetomidine—Blood alkaline phosphatase increased—Topiramate—migraine	0.000517	0.00286	CcSEcCtD
Dexmedetomidine—Convulsion—Propranolol—migraine	0.000515	0.00286	CcSEcCtD
Dexmedetomidine—Constipation—Amitriptyline—migraine	0.00051	0.00283	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Gabapentin—migraine	0.000508	0.00282	CcSEcCtD
Dexmedetomidine—Agitation—Verapamil—migraine	0.000503	0.00279	CcSEcCtD
Dexmedetomidine—Pneumonia—Valproic Acid—migraine	0.000499	0.00277	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Amitriptyline—migraine	0.000491	0.00272	CcSEcCtD
Dexmedetomidine—Bronchospasm—Timolol—migraine	0.000488	0.0027	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Valproic Acid—migraine	0.000483	0.00268	CcSEcCtD
Dexmedetomidine—Infection—Propranolol—migraine	0.000482	0.00267	CcSEcCtD
Dexmedetomidine—Convulsion—Verapamil—migraine	0.000474	0.00263	CcSEcCtD
Dexmedetomidine—Hypertension—Verapamil—migraine	0.000472	0.00262	CcSEcCtD
Dexmedetomidine—Thirst—Topiramate—migraine	0.000472	0.00262	CcSEcCtD
Dexmedetomidine—Body temperature increased—Amitriptyline—migraine	0.000471	0.00261	CcSEcCtD
Dexmedetomidine—Hypoglycaemia—Topiramate—migraine	0.00046	0.00255	CcSEcCtD
Dexmedetomidine—Dry mouth—Verapamil—migraine	0.000456	0.00253	CcSEcCtD
Dexmedetomidine—Bronchospasm—Gabapentin—migraine	0.000454	0.00252	CcSEcCtD
Dexmedetomidine—Bradycardia—Valproic Acid—migraine	0.000454	0.00252	CcSEcCtD
Dexmedetomidine—Confusional state—Verapamil—migraine	0.00045	0.0025	CcSEcCtD
Dexmedetomidine—ADRA1B—brain—migraine	0.00045	0.0153	CbGeAlD
Dexmedetomidine—Sweating increased—Gabapentin—migraine	0.00045	0.00249	CcSEcCtD
Dexmedetomidine—Haemoglobin—Valproic Acid—migraine	0.000448	0.00248	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Timolol—migraine	0.000447	0.00248	CcSEcCtD
Dexmedetomidine—Haemorrhage—Valproic Acid—migraine	0.000446	0.00247	CcSEcCtD
Dexmedetomidine—Infection—Verapamil—migraine	0.000444	0.00246	CcSEcCtD
Dexmedetomidine—Hallucination—Valproic Acid—migraine	0.000443	0.00246	CcSEcCtD
Dexmedetomidine—ADRA1D—brain—migraine	0.00044	0.0149	CbGeAlD
Dexmedetomidine—Oedema peripheral—Valproic Acid—migraine	0.000439	0.00243	CcSEcCtD
Dexmedetomidine—Tachycardia—Verapamil—migraine	0.000436	0.00242	CcSEcCtD
Dexmedetomidine—Dyspnoea—Propranolol—migraine	0.000433	0.0024	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Verapamil—migraine	0.000432	0.00239	CcSEcCtD
Dexmedetomidine—Somnolence—Propranolol—migraine	0.000432	0.00239	CcSEcCtD
Dexmedetomidine—Visual impairment—Valproic Acid—migraine	0.00043	0.00238	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Propranolol—migraine	0.000419	0.00232	CcSEcCtD
Dexmedetomidine—Hypotension—Verapamil—migraine	0.000417	0.00231	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Gabapentin—migraine	0.000416	0.00231	CcSEcCtD
Dexmedetomidine—Pain—Propranolol—migraine	0.000415	0.0023	CcSEcCtD
Dexmedetomidine—Constipation—Propranolol—migraine	0.000415	0.0023	CcSEcCtD
Dexmedetomidine—Pneumonia—Gabapentin—migraine	0.000414	0.0023	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Topiramate—migraine	0.000409	0.00227	CcSEcCtD
Dexmedetomidine—Diarrhoea—Amitriptyline—migraine	0.000408	0.00226	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Gabapentin—migraine	0.000406	0.00225	CcSEcCtD
Dexmedetomidine—Aspartate aminotransferase increased—Topiramate—migraine	0.000405	0.00224	CcSEcCtD
Dexmedetomidine—Angiopathy—Valproic Acid—migraine	0.000404	0.00224	CcSEcCtD
Dexmedetomidine—Bradycardia—Timolol—migraine	0.000404	0.00224	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Gabapentin—migraine	0.000403	0.00224	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Gabapentin—migraine	0.000403	0.00224	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Valproic Acid—migraine	0.000402	0.00223	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Gabapentin—migraine	0.0004	0.00222	CcSEcCtD
Dexmedetomidine—Chills—Valproic Acid—migraine	0.0004	0.00222	CcSEcCtD
Dexmedetomidine—Arrhythmia—Valproic Acid—migraine	0.000398	0.00221	CcSEcCtD
Dexmedetomidine—Dyspnoea—Verapamil—migraine	0.000398	0.00221	CcSEcCtD
Dexmedetomidine—Somnolence—Verapamil—migraine	0.000397	0.0022	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Propranolol—migraine	0.000397	0.0022	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Topiramate—migraine	0.000396	0.0022	CcSEcCtD
Dexmedetomidine—Hallucination—Timolol—migraine	0.000395	0.00219	CcSEcCtD
Dexmedetomidine—Dizziness—Amitriptyline—migraine	0.000394	0.00219	CcSEcCtD
Dexmedetomidine—Abdominal distension—Topiramate—migraine	0.000391	0.00217	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Timolol—migraine	0.000391	0.00217	CcSEcCtD
Dexmedetomidine—Mental disorder—Valproic Acid—migraine	0.00039	0.00217	CcSEcCtD
Dexmedetomidine—Malnutrition—Valproic Acid—migraine	0.000388	0.00215	CcSEcCtD
Dexmedetomidine—Abdominal pain—Propranolol—migraine	0.000384	0.00213	CcSEcCtD
Dexmedetomidine—Body temperature increased—Propranolol—migraine	0.000384	0.00213	CcSEcCtD
Dexmedetomidine—CYP2E1—cardiovascular system—migraine	0.000383	0.013	CbGeAlD
Dexmedetomidine—Visual impairment—Timolol—migraine	0.000382	0.00212	CcSEcCtD
Dexmedetomidine—Constipation—Verapamil—migraine	0.000382	0.00212	CcSEcCtD
Dexmedetomidine—Pain—Verapamil—migraine	0.000382	0.00212	CcSEcCtD
Dexmedetomidine—Vomiting—Amitriptyline—migraine	0.000379	0.0021	CcSEcCtD
Dexmedetomidine—Sweating increased—Topiramate—migraine	0.000378	0.0021	CcSEcCtD
Dexmedetomidine—Bradycardia—Gabapentin—migraine	0.000376	0.00209	CcSEcCtD
Dexmedetomidine—Rash—Amitriptyline—migraine	0.000376	0.00208	CcSEcCtD
Dexmedetomidine—Dermatitis—Amitriptyline—migraine	0.000376	0.00208	CcSEcCtD
Dexmedetomidine—SLC6A2—head—migraine	0.000375	0.0127	CbGeAlD
Dexmedetomidine—Headache—Amitriptyline—migraine	0.000374	0.00207	CcSEcCtD
Dexmedetomidine—CYP2D6—brainstem—migraine	0.000372	0.0126	CbGeAlD
Dexmedetomidine—Haemorrhage—Gabapentin—migraine	0.000369	0.00205	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Timolol—migraine	0.000368	0.00204	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Verapamil—migraine	0.000368	0.00204	CcSEcCtD
Dexmedetomidine—Hallucination—Gabapentin—migraine	0.000368	0.00204	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Gabapentin—migraine	0.000364	0.00202	CcSEcCtD
Dexmedetomidine—Angiopathy—Timolol—migraine	0.00036	0.002	CcSEcCtD
Dexmedetomidine—Anaemia—Valproic Acid—migraine	0.000359	0.00199	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Timolol—migraine	0.000358	0.00198	CcSEcCtD
Dexmedetomidine—Agitation—Valproic Acid—migraine	0.000357	0.00198	CcSEcCtD
Dexmedetomidine—Visual impairment—Gabapentin—migraine	0.000356	0.00197	CcSEcCtD
Dexmedetomidine—SLC6A2—nervous system—migraine	0.000356	0.0121	CbGeAlD
Dexmedetomidine—Arrhythmia—Timolol—migraine	0.000354	0.00197	CcSEcCtD
Dexmedetomidine—Nausea—Amitriptyline—migraine	0.000354	0.00196	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Topiramate—migraine	0.00035	0.00194	CcSEcCtD
Dexmedetomidine—Pneumonia—Topiramate—migraine	0.000348	0.00193	CcSEcCtD
Dexmedetomidine—Mental disorder—Timolol—migraine	0.000348	0.00193	CcSEcCtD
Dexmedetomidine—Malnutrition—Timolol—migraine	0.000345	0.00192	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Gabapentin—migraine	0.000343	0.0019	CcSEcCtD
Dexmedetomidine—SLC6A2—central nervous system—migraine	0.000343	0.0116	CbGeAlD
Dexmedetomidine—Neuropathy peripheral—Topiramate—migraine	0.000339	0.00188	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Topiramate—migraine	0.000337	0.00187	CcSEcCtD
Dexmedetomidine—Hypertension—Valproic Acid—migraine	0.000335	0.00186	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Gabapentin—migraine	0.000333	0.00185	CcSEcCtD
Dexmedetomidine—ADRA2C—head—migraine	0.000332	0.0113	CbGeAlD
Dexmedetomidine—Diarrhoea—Propranolol—migraine	0.000332	0.00184	CcSEcCtD
Dexmedetomidine—Chills—Gabapentin—migraine	0.000332	0.00184	CcSEcCtD
Dexmedetomidine—Anxiety—Valproic Acid—migraine	0.000329	0.00183	CcSEcCtD
Dexmedetomidine—Mental disorder—Gabapentin—migraine	0.000324	0.0018	CcSEcCtD
Dexmedetomidine—Dry mouth—Valproic Acid—migraine	0.000323	0.00179	CcSEcCtD
Dexmedetomidine—Malnutrition—Gabapentin—migraine	0.000322	0.00178	CcSEcCtD
Dexmedetomidine—Dizziness—Propranolol—migraine	0.000321	0.00178	CcSEcCtD
Dexmedetomidine—Confusional state—Valproic Acid—migraine	0.000319	0.00177	CcSEcCtD
Dexmedetomidine—Bradycardia—Topiramate—migraine	0.000316	0.00175	CcSEcCtD
Dexmedetomidine—ADRA2C—nervous system—migraine	0.000315	0.0107	CbGeAlD
Dexmedetomidine—Infection—Valproic Acid—migraine	0.000315	0.00174	CcSEcCtD
Dexmedetomidine—Haemoglobin—Topiramate—migraine	0.000312	0.00173	CcSEcCtD
Dexmedetomidine—Haemorrhage—Topiramate—migraine	0.000311	0.00172	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Valproic Acid—migraine	0.00031	0.00172	CcSEcCtD
Dexmedetomidine—Hallucination—Topiramate—migraine	0.000309	0.00172	CcSEcCtD
Dexmedetomidine—Tachycardia—Valproic Acid—migraine	0.000309	0.00171	CcSEcCtD
Dexmedetomidine—Vomiting—Propranolol—migraine	0.000309	0.00171	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Topiramate—migraine	0.000306	0.0017	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Valproic Acid—migraine	0.000306	0.0017	CcSEcCtD
Dexmedetomidine—Rash—Propranolol—migraine	0.000306	0.0017	CcSEcCtD
Dexmedetomidine—Dermatitis—Propranolol—migraine	0.000306	0.0017	CcSEcCtD
Dexmedetomidine—Diarrhoea—Verapamil—migraine	0.000306	0.00169	CcSEcCtD
Dexmedetomidine—ADRA2C—central nervous system—migraine	0.000303	0.0103	CbGeAlD
Dexmedetomidine—Visual impairment—Topiramate—migraine	0.0003	0.00166	CcSEcCtD
Dexmedetomidine—Hypertension—Timolol—migraine	0.000298	0.00165	CcSEcCtD
Dexmedetomidine—Anaemia—Gabapentin—migraine	0.000297	0.00165	CcSEcCtD
Dexmedetomidine—ADRA2C—cerebellum—migraine	0.000297	0.0101	CbGeAlD
Dexmedetomidine—Hypotension—Valproic Acid—migraine	0.000296	0.00164	CcSEcCtD
Dexmedetomidine—Agitation—Gabapentin—migraine	0.000296	0.00164	CcSEcCtD
Dexmedetomidine—Dizziness—Verapamil—migraine	0.000295	0.00164	CcSEcCtD
Dexmedetomidine—Anxiety—Timolol—migraine	0.000293	0.00163	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Topiramate—migraine	0.000288	0.0016	CcSEcCtD
Dexmedetomidine—Nausea—Propranolol—migraine	0.000288	0.0016	CcSEcCtD
Dexmedetomidine—Dry mouth—Timolol—migraine	0.000288	0.00159	CcSEcCtD
Dexmedetomidine—CYP1A1—head—migraine	0.000285	0.00965	CbGeAlD
Dexmedetomidine—Confusional state—Timolol—migraine	0.000284	0.00158	CcSEcCtD
Dexmedetomidine—Vomiting—Verapamil—migraine	0.000284	0.00157	CcSEcCtD
Dexmedetomidine—Dyspnoea—Valproic Acid—migraine	0.000282	0.00157	CcSEcCtD
Dexmedetomidine—Angiopathy—Topiramate—migraine	0.000282	0.00156	CcSEcCtD
Dexmedetomidine—Rash—Verapamil—migraine	0.000282	0.00156	CcSEcCtD
Dexmedetomidine—Somnolence—Valproic Acid—migraine	0.000281	0.00156	CcSEcCtD
Dexmedetomidine—Dermatitis—Verapamil—migraine	0.000281	0.00156	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Topiramate—migraine	0.00028	0.00155	CcSEcCtD
Dexmedetomidine—Infection—Timolol—migraine	0.00028	0.00155	CcSEcCtD
Dexmedetomidine—Headache—Verapamil—migraine	0.00028	0.00155	CcSEcCtD
Dexmedetomidine—Chills—Topiramate—migraine	0.000279	0.00155	CcSEcCtD
Dexmedetomidine—Convulsion—Gabapentin—migraine	0.000279	0.00155	CcSEcCtD
Dexmedetomidine—Hypertension—Gabapentin—migraine	0.000278	0.00154	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Valproic Acid—migraine	0.000273	0.00152	CcSEcCtD
Dexmedetomidine—Anxiety—Gabapentin—migraine	0.000273	0.00151	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Timolol—migraine	0.000272	0.00151	CcSEcCtD
Dexmedetomidine—Mental disorder—Topiramate—migraine	0.000272	0.00151	CcSEcCtD
Dexmedetomidine—SLC6A2—brain—migraine	0.000272	0.00922	CbGeAlD
Dexmedetomidine—Pain—Valproic Acid—migraine	0.000271	0.0015	CcSEcCtD
Dexmedetomidine—Constipation—Valproic Acid—migraine	0.000271	0.0015	CcSEcCtD
Dexmedetomidine—Malnutrition—Topiramate—migraine	0.000271	0.0015	CcSEcCtD
Dexmedetomidine—CYP1A1—nervous system—migraine	0.00027	0.00915	CbGeAlD
Dexmedetomidine—Dry mouth—Gabapentin—migraine	0.000268	0.00149	CcSEcCtD
Dexmedetomidine—ADRA2A—head—migraine	0.000265	0.009	CbGeAlD
Dexmedetomidine—Nausea—Verapamil—migraine	0.000265	0.00147	CcSEcCtD
Dexmedetomidine—Confusional state—Gabapentin—migraine	0.000265	0.00147	CcSEcCtD
Dexmedetomidine—Hypotension—Timolol—migraine	0.000263	0.00146	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Valproic Acid—migraine	0.000261	0.00145	CcSEcCtD
Dexmedetomidine—Infection—Gabapentin—migraine	0.000261	0.00145	CcSEcCtD
Dexmedetomidine—CYP1A1—central nervous system—migraine	0.00026	0.00881	CbGeAlD
Dexmedetomidine—CYP2E1—head—migraine	0.00026	0.0088	CbGeAlD
Dexmedetomidine—Gastrointestinal pain—Valproic Acid—migraine	0.000259	0.00144	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Gabapentin—migraine	0.000257	0.00143	CcSEcCtD
Dexmedetomidine—Tachycardia—Gabapentin—migraine	0.000256	0.00142	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Gabapentin—migraine	0.000254	0.00141	CcSEcCtD
Dexmedetomidine—ADRA2A—nervous system—migraine	0.000252	0.00853	CbGeAlD
Dexmedetomidine—Dyspnoea—Timolol—migraine	0.000251	0.00139	CcSEcCtD
Dexmedetomidine—Somnolence—Timolol—migraine	0.000251	0.00139	CcSEcCtD
Dexmedetomidine—Abdominal pain—Valproic Acid—migraine	0.00025	0.00139	CcSEcCtD
Dexmedetomidine—Body temperature increased—Valproic Acid—migraine	0.00025	0.00139	CcSEcCtD
Dexmedetomidine—Anaemia—Topiramate—migraine	0.00025	0.00139	CcSEcCtD
Dexmedetomidine—Agitation—Topiramate—migraine	0.000249	0.00138	CcSEcCtD
Dexmedetomidine—CYP2E1—nervous system—migraine	0.000246	0.00834	CbGeAlD
Dexmedetomidine—Hypotension—Gabapentin—migraine	0.000245	0.00136	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Timolol—migraine	0.000243	0.00135	CcSEcCtD
Dexmedetomidine—ADRA2A—central nervous system—migraine	0.000242	0.00821	CbGeAlD
Dexmedetomidine—Pain—Timolol—migraine	0.000241	0.00134	CcSEcCtD
Dexmedetomidine—ADRA2C—brain—migraine	0.000241	0.00817	CbGeAlD
Dexmedetomidine—CYP2E1—central nervous system—migraine	0.000237	0.00803	CbGeAlD
Dexmedetomidine—ADRA2A—cerebellum—migraine	0.000237	0.00803	CbGeAlD
Dexmedetomidine—Convulsion—Topiramate—migraine	0.000234	0.0013	CcSEcCtD
Dexmedetomidine—Dyspnoea—Gabapentin—migraine	0.000234	0.0013	CcSEcCtD
Dexmedetomidine—Hypertension—Topiramate—migraine	0.000234	0.0013	CcSEcCtD
Dexmedetomidine—Somnolence—Gabapentin—migraine	0.000233	0.00129	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Timolol—migraine	0.000232	0.00129	CcSEcCtD
Dexmedetomidine—CYP2E1—cerebellum—migraine	0.000232	0.00785	CbGeAlD
Dexmedetomidine—Gastrointestinal pain—Timolol—migraine	0.00023	0.00128	CcSEcCtD
Dexmedetomidine—Anxiety—Topiramate—migraine	0.00023	0.00127	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Gabapentin—migraine	0.000227	0.00126	CcSEcCtD
Dexmedetomidine—Dry mouth—Topiramate—migraine	0.000225	0.00125	CcSEcCtD
Dexmedetomidine—Constipation—Gabapentin—migraine	0.000224	0.00124	CcSEcCtD
Dexmedetomidine—Pain—Gabapentin—migraine	0.000224	0.00124	CcSEcCtD
Dexmedetomidine—Abdominal pain—Timolol—migraine	0.000223	0.00124	CcSEcCtD
Dexmedetomidine—Body temperature increased—Timolol—migraine	0.000223	0.00124	CcSEcCtD
Dexmedetomidine—Confusional state—Topiramate—migraine	0.000223	0.00123	CcSEcCtD
Dexmedetomidine—Infection—Topiramate—migraine	0.000219	0.00122	CcSEcCtD
Dexmedetomidine—Diarrhoea—Valproic Acid—migraine	0.000217	0.0012	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Gabapentin—migraine	0.000216	0.0012	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Topiramate—migraine	0.000216	0.0012	CcSEcCtD
Dexmedetomidine—Tachycardia—Topiramate—migraine	0.000216	0.0012	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Gabapentin—migraine	0.000215	0.00119	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Topiramate—migraine	0.000213	0.00118	CcSEcCtD
Dexmedetomidine—Dizziness—Valproic Acid—migraine	0.000209	0.00116	CcSEcCtD
Dexmedetomidine—Abdominal pain—Gabapentin—migraine	0.000208	0.00115	CcSEcCtD
Dexmedetomidine—Body temperature increased—Gabapentin—migraine	0.000208	0.00115	CcSEcCtD
Dexmedetomidine—Hypotension—Topiramate—migraine	0.000206	0.00114	CcSEcCtD
Dexmedetomidine—CYP1A1—brain—migraine	0.000206	0.00699	CbGeAlD
Dexmedetomidine—CYP2D6—head—migraine	0.000205	0.00697	CbGeAlD
Dexmedetomidine—Vomiting—Valproic Acid—migraine	0.000201	0.00112	CcSEcCtD
Dexmedetomidine—Rash—Valproic Acid—migraine	0.0002	0.00111	CcSEcCtD
Dexmedetomidine—Dermatitis—Valproic Acid—migraine	0.000199	0.00111	CcSEcCtD
Dexmedetomidine—Headache—Valproic Acid—migraine	0.000198	0.0011	CcSEcCtD
Dexmedetomidine—Dyspnoea—Topiramate—migraine	0.000197	0.00109	CcSEcCtD
Dexmedetomidine—Somnolence—Topiramate—migraine	0.000196	0.00109	CcSEcCtD
Dexmedetomidine—CYP2D6—nervous system—migraine	0.000195	0.00661	CbGeAlD
Dexmedetomidine—Diarrhoea—Timolol—migraine	0.000193	0.00107	CcSEcCtD
Dexmedetomidine—ADRA2A—brain—migraine	0.000192	0.00652	CbGeAlD
Dexmedetomidine—Gastrointestinal disorder—Topiramate—migraine	0.000191	0.00106	CcSEcCtD
Dexmedetomidine—Constipation—Topiramate—migraine	0.000189	0.00105	CcSEcCtD
Dexmedetomidine—Pain—Topiramate—migraine	0.000189	0.00105	CcSEcCtD
Dexmedetomidine—Nausea—Valproic Acid—migraine	0.000188	0.00104	CcSEcCtD
Dexmedetomidine—CYP2E1—brain—migraine	0.000188	0.00638	CbGeAlD
Dexmedetomidine—CYP2D6—central nervous system—migraine	0.000188	0.00636	CbGeAlD
Dexmedetomidine—Dizziness—Timolol—migraine	0.000186	0.00103	CcSEcCtD
Dexmedetomidine—CYP2D6—cerebellum—migraine	0.000183	0.00622	CbGeAlD
Dexmedetomidine—Feeling abnormal—Topiramate—migraine	0.000182	0.00101	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Topiramate—migraine	0.000181	0.001	CcSEcCtD
Dexmedetomidine—Diarrhoea—Gabapentin—migraine	0.00018	0.000996	CcSEcCtD
Dexmedetomidine—Vomiting—Timolol—migraine	0.000179	0.000994	CcSEcCtD
Dexmedetomidine—Rash—Timolol—migraine	0.000178	0.000986	CcSEcCtD
Dexmedetomidine—Dermatitis—Timolol—migraine	0.000178	0.000985	CcSEcCtD
Dexmedetomidine—Headache—Timolol—migraine	0.000177	0.000979	CcSEcCtD
Dexmedetomidine—Abdominal pain—Topiramate—migraine	0.000175	0.000968	CcSEcCtD
Dexmedetomidine—Body temperature increased—Topiramate—migraine	0.000175	0.000968	CcSEcCtD
Dexmedetomidine—Dizziness—Gabapentin—migraine	0.000174	0.000963	CcSEcCtD
Dexmedetomidine—Nausea—Timolol—migraine	0.000167	0.000929	CcSEcCtD
Dexmedetomidine—Vomiting—Gabapentin—migraine	0.000167	0.000926	CcSEcCtD
Dexmedetomidine—Rash—Gabapentin—migraine	0.000166	0.000918	CcSEcCtD
Dexmedetomidine—Dermatitis—Gabapentin—migraine	0.000165	0.000917	CcSEcCtD
Dexmedetomidine—Headache—Gabapentin—migraine	0.000164	0.000912	CcSEcCtD
Dexmedetomidine—Nausea—Gabapentin—migraine	0.000156	0.000865	CcSEcCtD
Dexmedetomidine—Diarrhoea—Topiramate—migraine	0.000151	0.000838	CcSEcCtD
Dexmedetomidine—CYP2D6—brain—migraine	0.000149	0.00505	CbGeAlD
Dexmedetomidine—Dizziness—Topiramate—migraine	0.000146	0.00081	CcSEcCtD
Dexmedetomidine—Vomiting—Topiramate—migraine	0.00014	0.000779	CcSEcCtD
Dexmedetomidine—Rash—Topiramate—migraine	0.000139	0.000772	CcSEcCtD
Dexmedetomidine—Dermatitis—Topiramate—migraine	0.000139	0.000771	CcSEcCtD
Dexmedetomidine—Headache—Topiramate—migraine	0.000138	0.000767	CcSEcCtD
Dexmedetomidine—Nausea—Topiramate—migraine	0.000131	0.000727	CcSEcCtD
Dexmedetomidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	9.55e-05	0.000893	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—HTR2B—migraine	9.53e-05	0.000891	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—NPS—migraine	9.52e-05	0.00089	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—TAC1—migraine	9.52e-05	0.00089	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—HTR1D—migraine	9.52e-05	0.00089	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR ligand binding—CALCA—migraine	9.51e-05	0.000889	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR ligand binding—HTR2C—migraine	9.49e-05	0.000887	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—HTR2B—migraine	9.47e-05	0.000885	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—HTR1D—migraine	9.37e-05	0.000876	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—HTR2C—migraine	9.34e-05	0.000873	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—HTR1D—migraine	9.25e-05	0.000865	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR ligand binding—EDNRA—migraine	9.23e-05	0.000863	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—EDNRA—migraine	9.08e-05	0.000849	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	9.06e-05	0.000847	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	8.92e-05	0.000834	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR ligand binding—HTR7—migraine	8.89e-05	0.000831	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR ligand binding—CALCA—migraine	8.88e-05	0.00083	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	8.86e-05	0.000828	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—HTR2B—migraine	8.85e-05	0.000827	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	8.78e-05	0.000821	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—CALCA—migraine	8.74e-05	0.000817	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—HTR2B—migraine	8.71e-05	0.000814	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—HTR1D—migraine	8.64e-05	0.000808	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—HTR2B—migraine	8.6e-05	0.000804	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—HTR1D—migraine	8.51e-05	0.000795	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CALCRL—migraine	8.33e-05	0.000779	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—RAMP1—migraine	8.33e-05	0.000779	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR ligand binding—HTR7—migraine	8.31e-05	0.000777	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—HTR1B—migraine	8.29e-05	0.000775	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	8.18e-05	0.000765	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—HTR7—migraine	8.18e-05	0.000764	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—HTR2B—migraine	8.03e-05	0.000751	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—HTR1A—migraine	7.98e-05	0.000746	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—HTR2B—migraine	7.91e-05	0.000739	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—NPS—migraine	7.86e-05	0.000734	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—TAC1—migraine	7.86e-05	0.000734	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—HTR1D—migraine	7.73e-05	0.000723	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—HTR2C—migraine	7.7e-05	0.00072	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	7.64e-05	0.000714	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CALCRL—migraine	7.52e-05	0.000703	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—RAMP1—migraine	7.52e-05	0.000703	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	7.52e-05	0.000703	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—EDNRA—migraine	7.5e-05	0.000701	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	7.24e-05	0.000677	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—CALCA—migraine	7.21e-05	0.000674	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—HTR2B—migraine	7.19e-05	0.000672	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CALCRL—migraine	7.03e-05	0.000657	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—RAMP1—migraine	7.03e-05	0.000657	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—HTR1D—migraine	7.02e-05	0.000656	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—RAMP1—migraine	6.92e-05	0.000646	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CALCRL—migraine	6.92e-05	0.000646	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR ligand binding—HTR2A—migraine	6.9e-05	0.000645	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—HTR1B—migraine	6.84e-05	0.000639	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	6.83e-05	0.000639	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	6.83e-05	0.000639	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—HTR7—migraine	6.75e-05	0.000631	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—HTR1A—migraine	6.58e-05	0.000615	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—HTR2B—migraine	6.53e-05	0.00061	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—NPS—migraine	6.48e-05	0.000606	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—TAC1—migraine	6.48e-05	0.000606	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—CACNA1A—migraine	6.37e-05	0.000595	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—HTR2C—migraine	6.36e-05	0.000594	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR ligand binding—HTR2A—migraine	6.23e-05	0.000582	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—HTR1B—migraine	6.21e-05	0.00058	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	6.21e-05	0.00058	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—EDNRA—migraine	6.18e-05	0.000578	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—HTR1B—migraine	6.17e-05	0.000577	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—HTR1D—migraine	6.05e-05	0.000566	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—HTR1A—migraine	5.98e-05	0.000559	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—CALCA—migraine	5.95e-05	0.000556	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—HTR1A—migraine	5.94e-05	0.000555	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—NPS—migraine	5.89e-05	0.00055	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—TAC1—migraine	5.89e-05	0.00055	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—TAC1—migraine	5.85e-05	0.000547	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—NPS—migraine	5.85e-05	0.000547	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR ligand binding—HTR2A—migraine	5.82e-05	0.000544	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—HTR2C—migraine	5.77e-05	0.00054	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—HTR1B—migraine	5.77e-05	0.000539	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—HTR2C—migraine	5.74e-05	0.000536	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—HTR2A—migraine	5.73e-05	0.000535	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—RAMP1—migraine	5.71e-05	0.000534	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CALCRL—migraine	5.71e-05	0.000534	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—HTR1B—migraine	5.68e-05	0.000531	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—HTR2B—migraine	5.63e-05	0.000526	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—EDNRA—migraine	5.62e-05	0.000525	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—HTR1B—migraine	5.61e-05	0.000524	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—EDNRA—migraine	5.58e-05	0.000522	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—HTR7—migraine	5.57e-05	0.00052	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—HTR1A—migraine	5.55e-05	0.000519	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—TAC1—migraine	5.47e-05	0.000511	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—NPS—migraine	5.47e-05	0.000511	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—HTR1D—migraine	5.47e-05	0.000511	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—HTR1A—migraine	5.46e-05	0.000511	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—CALCA—migraine	5.41e-05	0.000505	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—HTR1A—migraine	5.4e-05	0.000504	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—TAC1—migraine	5.38e-05	0.000503	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—NPS—migraine	5.38e-05	0.000503	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—CALCA—migraine	5.37e-05	0.000502	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—HTR2C—migraine	5.36e-05	0.000501	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—TAC1—migraine	5.31e-05	0.000497	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—NPS—migraine	5.31e-05	0.000497	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—HTR2C—migraine	5.28e-05	0.000493	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—HTR1B—migraine	5.24e-05	0.000489	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—EDNRA—migraine	5.21e-05	0.000487	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—HTR2C—migraine	5.21e-05	0.000487	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—CACNA1A—migraine	5.17e-05	0.000484	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—HTR1B—migraine	5.15e-05	0.000482	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—EDNRA—migraine	5.13e-05	0.00048	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—HTR1D—migraine	5.11e-05	0.000477	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—HTR2B—migraine	5.08e-05	0.000475	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—EDNRA—migraine	5.07e-05	0.000474	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—HTR7—migraine	5.06e-05	0.000473	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—HTR1A—migraine	5.04e-05	0.000471	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—HTR7—migraine	5.03e-05	0.00047	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—HTR1D—migraine	5.02e-05	0.00047	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—CALCA—migraine	5.02e-05	0.000469	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—TAC1—migraine	4.96e-05	0.000464	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—NPS—migraine	4.96e-05	0.000464	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—HTR1A—migraine	4.96e-05	0.000464	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—LRP1—migraine	4.96e-05	0.000463	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—CALCA—migraine	4.94e-05	0.000462	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—TAC1—migraine	4.89e-05	0.000457	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—NPS—migraine	4.89e-05	0.000457	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—CALCA—migraine	4.88e-05	0.000456	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—HTR2C—migraine	4.87e-05	0.000455	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—HTR2C—migraine	4.79e-05	0.000448	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—CACNA1A—migraine	4.75e-05	0.000444	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—HTR2B—migraine	4.75e-05	0.000444	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—EDNRA—migraine	4.74e-05	0.000443	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—HTR2A—migraine	4.73e-05	0.000442	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—HTR7—migraine	4.7e-05	0.000439	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—HTR1B—migraine	4.68e-05	0.000438	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—HTR2B—migraine	4.67e-05	0.000437	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—EDNRA—migraine	4.66e-05	0.000436	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—HTR7—migraine	4.62e-05	0.000432	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—HTR7—migraine	4.56e-05	0.000427	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—CALCA—migraine	4.56e-05	0.000426	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—HTR1A—migraine	4.51e-05	0.000421	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—CALCA—migraine	4.49e-05	0.000419	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—CACNA1A—migraine	4.48e-05	0.000419	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—LRP1—migraine	4.47e-05	0.000418	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—NPS—migraine	4.44e-05	0.000415	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—TAC1—migraine	4.44e-05	0.000415	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—HTR2C—migraine	4.35e-05	0.000407	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—HTR7—migraine	4.26e-05	0.000399	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—HTR1B—migraine	4.25e-05	0.000398	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—EDNRA—migraine	4.24e-05	0.000396	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—HTR7—migraine	4.2e-05	0.000392	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—LRP1—migraine	4.18e-05	0.000391	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HTR1D—migraine	4.15e-05	0.000388	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—LRP1—migraine	4.11e-05	0.000384	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—HTR1A—migraine	4.09e-05	0.000383	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—CALCA—migraine	4.08e-05	0.000381	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—NPS—migraine	4.03e-05	0.000377	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—TAC1—migraine	4.03e-05	0.000377	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—HTR2C—migraine	3.95e-05	0.00037	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—HTR2A—migraine	3.9e-05	0.000365	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HTR2B—migraine	3.86e-05	0.00036	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—EDNRA—migraine	3.85e-05	0.00036	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—HTR7—migraine	3.81e-05	0.000357	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—NOTCH4—migraine	3.8e-05	0.000355	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CALCA—migraine	3.7e-05	0.000346	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—HTR1B—migraine	3.67e-05	0.000343	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—HTR2A—migraine	3.54e-05	0.000331	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—HTR1A—migraine	3.53e-05	0.00033	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—HTR2A—migraine	3.52e-05	0.000329	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—TAC1—migraine	3.48e-05	0.000325	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—NPS—migraine	3.48e-05	0.000325	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—PGR—migraine	3.48e-05	0.000325	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—HTR7—migraine	3.46e-05	0.000324	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—NOTCH4—migraine	3.43e-05	0.000321	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—HTR2C—migraine	3.41e-05	0.000319	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—LRP1—migraine	3.39e-05	0.000317	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CACNA1A—migraine	3.37e-05	0.000315	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—EDNRA—migraine	3.32e-05	0.00031	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—HTR1B—migraine	3.31e-05	0.00031	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—HTR2A—migraine	3.29e-05	0.000307	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—HTR2A—migraine	3.24e-05	0.000303	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—NOTCH3—migraine	3.23e-05	0.000302	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NOTCH4—migraine	3.21e-05	0.0003	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—HTR2A—migraine	3.2e-05	0.000299	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CALCA—migraine	3.19e-05	0.000298	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—HTR1A—migraine	3.19e-05	0.000298	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NOTCH4—migraine	3.16e-05	0.000295	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TAC1—migraine	3.14e-05	0.000293	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—PGR—migraine	3.14e-05	0.000293	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—NPS—migraine	3.14e-05	0.000293	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—HTR1B—migraine	3.09e-05	0.000289	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—HTR2C—migraine	3.08e-05	0.000288	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—HTR1B—migraine	3.04e-05	0.000285	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—EDNRA—migraine	2.99e-05	0.00028	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—HTR7—migraine	2.99e-05	0.000279	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—HTR2A—migraine	2.99e-05	0.000279	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—HTR1A—migraine	2.98e-05	0.000278	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—HTR2A—migraine	2.94e-05	0.000275	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TAC1—migraine	2.93e-05	0.000274	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PGR—migraine	2.93e-05	0.000274	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NPS—migraine	2.93e-05	0.000274	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—HTR1A—migraine	2.93e-05	0.000274	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—NOTCH3—migraine	2.92e-05	0.000273	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TAC1—migraine	2.89e-05	0.00027	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NPS—migraine	2.89e-05	0.00027	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PGR—migraine	2.89e-05	0.00027	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CALCA—migraine	2.88e-05	0.000269	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—HTR2C—migraine	2.88e-05	0.000269	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CACNA1A—migraine	2.86e-05	0.000267	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—HTR2C—migraine	2.83e-05	0.000265	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—EDNRA—migraine	2.8e-05	0.000262	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—EDNRA—migraine	2.75e-05	0.000257	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NOTCH3—migraine	2.73e-05	0.000255	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—HTR7—migraine	2.7e-05	0.000252	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CALCA—migraine	2.69e-05	0.000252	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NOTCH3—migraine	2.68e-05	0.000251	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—HTR2A—migraine	2.67e-05	0.00025	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CALCA—migraine	2.65e-05	0.000248	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NOTCH4—migraine	2.6e-05	0.000243	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—TGFBR2—migraine	2.57e-05	0.00024	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—HTR7—migraine	2.52e-05	0.000235	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HTR1B—migraine	2.51e-05	0.000235	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—HTR7—migraine	2.48e-05	0.000232	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—HTR2A—migraine	2.43e-05	0.000227	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HTR1A—migraine	2.42e-05	0.000226	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NPS—migraine	2.38e-05	0.000223	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TAC1—migraine	2.38e-05	0.000223	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PGR—migraine	2.38e-05	0.000223	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HTR2C—migraine	2.34e-05	0.000218	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TGFBR2—migraine	2.32e-05	0.000217	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—EDNRA—migraine	2.27e-05	0.000212	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NOTCH3—migraine	2.21e-05	0.000207	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CALCA—migraine	2.19e-05	0.000204	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TGFBR2—migraine	2.17e-05	0.000203	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TGFBR2—migraine	2.13e-05	0.0002	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—MTHFR—migraine	2.11e-05	0.000197	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—HTR2A—migraine	2.09e-05	0.000196	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HTR7—migraine	2.05e-05	0.000191	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—HTR2A—migraine	1.89e-05	0.000177	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—ESR1—migraine	1.86e-05	0.000174	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—HTR2A—migraine	1.76e-05	0.000165	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TGFBR2—migraine	1.76e-05	0.000165	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—HTR2A—migraine	1.74e-05	0.000162	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—MTHFR—migraine	1.71e-05	0.00016	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—ESR1—migraine	1.68e-05	0.000157	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—MTHFR—migraine	1.57e-05	0.000147	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—ESR1—migraine	1.57e-05	0.000146	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—ESR1—migraine	1.54e-05	0.000144	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—MTHFR—migraine	1.48e-05	0.000138	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HTR2A—migraine	1.43e-05	0.000134	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—ESR1—migraine	1.27e-05	0.000119	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—MTHFR—migraine	1.12e-05	0.000104	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—MTHFR—migraine	9.45e-06	8.83e-05	CbGpPWpGaD
